Skip to content
★ Sign in to follow
BL

Barbara Lopez Kunz

Board Director
Director
Aptevo Therapeutics Inc.
Total declarations
8
Company
1
▲ Purchases (1 ops.)
€7,493
▼ Sales (0 ops.)
—

Latest filing published 10 Aug 2026 for Aptevo Therapeutics Inc..

Insider track record

Disclosed buys
1
Disclosed sells
0

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

No signal scores available.

Barbara Lopez Kunz: trading record in brief

All filings by Barbara Lopez Kunz on record concern Aptevo Therapeutics Inc., in the capacity of board member. Between 10 June 2019 and 6 August 2026, the trades on record add up to 8 filings.

Purchases make up the whole of the open-market record (1 purchase, €7,493). Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 7 option exercises.

On 10 August 2026 came the latest disclosure, an option exercise in Aptevo Therapeutics Inc. The clock since the last published purchase (11 June 2019) now reads 2,707 days. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Barbara Lopez Kunz

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations6 total

6 of 6 declarations